RYAN MICHAEL DAUER
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology MIAMI, FL NPI 1376938449
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology FL Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$4,301.92
- Category: General Payments
- Program years: PY2018–2024
- Record count: 205
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,695.72 across 76 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,667.96 | 75 |
| Education | $27.76 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $357.86 | 16 |
| ABBVIE INC. | $196.87 | 10 |
| QOL Medical, LLC | $191.44 | 12 |
| Celltrion USA Inc. | $176.22 | 2 |
| GENZYME CORPORATION | $137.53 | 7 |
| Regeneron Healthcare Solutions, Inc. | $124.11 | 5 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $87.81 | 4 |
| AIMMUNE THERAPEUTICS, INC. | $84.89 | 4 |
| Lilly USA, LLC | $60.47 | 3 |
| Ardelyx, Inc. | $53.76 | 2 |
| Gilead Sciences, Inc. | $49.44 | 2 |
| Phathom Pharmaceuticals, Inc. | $47.50 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $40.70 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.68 | 2 |
| Celgene Corporation | $17.60 | 1 |
| VIVUS LLC | $15.86 | 1 |
| EVOKE PHARMA, INC. | $13.98 | 1 |
By program year
Records — PY2024 (76)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.